News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Anthera Pharmaceuticals, Inc. Plans $70 Million IPO
September 16, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bizjournals.com -- A Hayward biotech focused on inflammatory diseases like from cardiovascular disease and lupus filed for one of the first U.S. biotech IPO in two years.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Immunology and inflammation
Neurocrine Goes to China To Grow Pipeline in up to $881M TransThera Deal
November 3, 2025
·
1 min read
·
Dan Samorodnitsky
Neuroscience
Roche Piles $55M Into Blood-Brain Barrier Tech With Manifold
November 3, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
UPDATE: Pfizer Files Lawsuits Against Novo Nordisk, Metsera To Stop Rival Bid
November 3, 2025
·
4 min read
·
Tristan Manalac
Editorial
Novo’s CEO Doesn’t Seem To Mind Being Big Pharma’s Villian
October 31, 2025
·
3 min read
·
Annalee Armstrong
